CI3D, Inc., is a privately held company.

CI3D medical products are in development and being prepared for clinical application. The Company's novel diagnostic system is designed to provide clinicians more efficient and effective means to define, treat and monitor incidence, therapeutic intervention and patient treatment modality outcomes of human vascular disease states.

This web site contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements.

CI3D medical technologies are pending design release and regulatory clearances to effect initial market release. Company products are presently NOT indicated for use by governing regulatory agencies. All information contained within this web site is for informational purposes only.